US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
イギリス
LSE
Dierig Holding AG (0N8T) 銘柄情報

Dierig Holding AG (0N8T)

17.60

0.00

(0.00%)

終了 7月5日 12:30AM

Dierig Holding AG (0N8T) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

17.60

( - )

買値

17.20

売値

18.00

出来高

0.00

0.00 日の範囲 0.00

17.60 52 週間の範囲 17.60

時価総額

前日終値

17.60

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

443 €

発行済株式数

4,103,100

配当利回り

0.25 (2.91%)

PER

9.05

1 株当たり利益 (EPS)

0.89

歳入

46.72M

純利益

3.67M

Dierig Holding AG engages in textiles business in Germany, rest of Europe, and internationally. The company offers raw and finished fabrics; and textiles for hotels, hospitals, homes, and care facilities. It also produces bed linen products under the Kaeppel and Fleuresse brands. In addition, it is ... Dierig Holding AG engages in textiles business in Germany, rest of Europe, and internationally. The company offers raw and finished fabrics; and textiles for hotels, hospitals, homes, and care facilities. It also produces bed linen products under the Kaeppel and Fleuresse brands. In addition, it is involved in the development, construction, rental, brokerage, management, and sales of real estate; real estate advising and valuation; project development; site management services. The company was founded in 1805 and is headquartered in Augsburg, Germany. Dierig Holding AG operates as a subsidiary of Textil-Treuhand GmbH. 詳細を表示

セクター

-

業界

-

ウェブサイト

dierig.de

本社

Augsburg, Germany

設立

2026

Dierig Holding AG is listed in the sector of the ロンドン証券取引所 with ticker 0N8T. The last closing price for Dierig was 17.60 €. Over the last year, Dierig shares have traded in a share price range of 17.60 € to 17.60 €.

Dierig currently has 4,103,100 shares in issue. The market capitalisation of Dierig is 72.21 € million. Dierig has a price to earnings ratio (PE ratio) of 9.05.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	17.6	17.6	17.6	0	17.6	DE
52	0	0	17.6	17.6	17.6	0	17.6	DE
156	0	0	17.6	17.6	17.6	0	17.6	DE
260	0	0	17.6	17.6	17.6	0	17.6	DE

0N8T - Frequently Asked Questions (FAQ)

What is the current Dierig Holding AG share price?

The current share price of Dierig Holding AG is 17.60 €

How many Dierig Holding AG shares are in issue?

Dierig Holding AG has 4,103,100 shares in issue

What is the market cap of Dierig Holding AG?

The market capitalisation of Dierig Holding AG is EUR 72.21M

What is the 1 year trading range for Dierig Holding AG share price?

Dierig Holding AG has traded in the range of 17.60 € to 17.60 € during the past year

What is the PE ratio of Dierig Holding AG?

The price to earnings ratio of Dierig Holding AG is 9.05

What is the cash to sales ratio of Dierig Holding AG?

The cash to sales ratio of Dierig Holding AG is 0.71

What is the registered address of Dierig Holding AG?

The registered address for Dierig Holding AG is Kirchbergstrasse 23, Augsburg, Bavaria, 86157

What is the Dierig Holding AG website address?

The website address for Dierig Holding AG is dierig.de

Twiggs333

Twiggs333 11分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 11分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 11分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

Twiggs333

Twiggs333 12分前

GW Pharmaceuticals / Epidiolex is the pathway precedent people should be studying with respect to psychedelic biotech.

Jazz Pharmaceuticals acquired GW Pharmaceuticals for approximately $7.2 billion.

Why does that matter for psychedelic biotech?

Because G

OMOLIVES

OMOLIVES 16分前

Happy Fourth of July to all!...and a big thank you to the French. Vive la France!:

https://x.com/Phoenix2A_1980s/status/2073453266428387385

4u2nv2

4u2nv2 17分前

Every filing from the time Paul and Ben took over said there were 3 preferred shareholders. The third one was never named. Now, it's interesting to question how Newby got controlling interest when we do not know all of the facts concerning what Ben really wanted to accomplish with taking on the comm

Eli's Gone

Eli's Gone 29分前

I'm in: 11-5-24-19

Eli's Gone

Eli's Gone 30分前

gfp927z

gfp927z 30分前

>>> Look At Who Joined Open USD To Understand Where Money Is Going

Forbes

by Zennon Kapron

Jul 02, 2026

https://www.forbes.com/sites/digital-assets/2026/07/02/look-at-who-joined-open-usd-to-understand-where-money-is-going/

Sammy boy

Sammy boy 36分前

Said it 4 months ago Bessent is the problem ! There is a reason he cold-cocked Tommy Boy.

misterfishman

misterfishman 48分前

Me too my side hobbies are researching new forms of energy from the enviroment,been at this for more than 20 yrs now and have accumilated a great deal oh knowledge.

Atlanta1

Atlanta1 51分前

Joey - Why do you waste time on this lunatic?

FeMike

FeMike 57分前

The original randomised primary endpoint (PFS) was negative and showed harm,

The simple fact that you don’t understand pseudo progression is more than enough to establish as also fact that you have no idea what you’re talking about.

1jas

1jas 1時間前

If you go to otcmarkets for AFFU news dated August 22 2023 it does mention AFFU and Dell partnership.

nyt

3 yrs down 79%. 5 yrs down 57%. 10 yrs down over 80%

gemstone57

gemstone57 1時間前

Happy Fourth of July guys we live in the greatest Nation on earth.

Tadaaa

Tadaaa 1時間前

johnydollar

johnydollar 1時間前

Have you ever wondered why clown fish like to hang out around the sea anemones........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆

GoodGuyBill

GoodGuyBill 1時間前

rcbindustry

rcbindustry 2時間前

I'm staying on the sidelines for now. Rocket Companies has potential over the long term, but I think the stock will continue to depend heavily on interest rates and the housing market. I'll be watching the next few quarters before becoming more optimistic.

Genz2

Genz2 2時間前

Now who would have thought of what Steven K Sprague came up with on X recently??? This country, Microsoft, Intel and Wave need Steven’s thinking!!!! If Steven’s court case is still in abeyance that is a real travesty!!! Steven is VERY UNIQUE in how he can masterfully come up with solutions that a

johnydollar

johnydollar 2時間前

You mean naked short enrichment right...........

😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 😹 😆 🤣 😂 Ƕ

Roman516

Roman516 2時間前

Happy 4th of July to all, GoodGuyBill, yes, I agree with you and your comment that "$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc)."

If in fact, DCVax-D is able to address the majority o

JusDePomme

JusDePomme 2時間前

I feel stress Canada lost today truenortth!!

Twiggs333

Twiggs333 2時間前

Curious to see how the next 6-12 months go.

Xtrackers MSCI Global Cl...

Bond 3625% until June 22...

Taiyo Yuden (PK)

Vontobel Financial Produ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。